First-party audit
Independent internal audit of your quality management system. Surfaces findings before a regulatory inspector does.
First-party, second-party, and pre-inspection audits for cannabis and pharmaceutical operations. Built on ISO 19011, EU GMP Part I and Part II, and documented IRCA PR 325 auditor credentials.
Independent findings and documented methodology. Audit outcomes depend on actual site and system status.
Self-assessment
Six questions covering programme management, auditor competence, and evidence-based audit activities. A structured diagnostic before commissioning an independent audit review.
We collect your email at the halfway point. Privacy policy.
Methodology
Based on ISO 19011:2018 (Guidelines for auditing management systems). Clear's auditors are qualified under IRCA and operate independently across European regulated industries, applying the same programme design and evidence criteria that external certification bodies expect to see.
Sample
“Do you have a documented audit programme that covers all relevant processes and departments?”
“Are auditors formally selected based on defined competence criteria and impartiality requirements?”
“How are audit findings tracked, assigned to responsible parties, and verified for closure?”
5 archetypes
First stages of the compliance journey. Basic systems and documentation not yet formally in place.
Compliance frameworks in progress, with partial implementation. Gap analysis and prioritisation are the main focus.
Mature systems with specific gaps remaining. Targeted remediation to close priority observations.
Near full compliance with refinement needs. Audit readiness and continuous improvement as the next horizon.
Next steps
The problem with self-assessment
Familiarity normalises risk. The team closest to the operation tends to underestimate what an external auditor will find on the first walk-through.
Credentials
IRCA PR 325 is a registered lead auditor certification issued through the Chartered Quality Institute. It is held individually and verifiable, distinct from corporate claims or course certificates.
Audit services
Scope is defined before starting. Each engagement produces a written report with classified findings.
Cluster A: Internal operations
Independent internal audit of your quality management system. Surfaces findings before a regulatory inspector does.
Simulated competent authority inspection: opening meeting, site walk, document requests, closing meeting, and written observations.
Focused review of documentation, site status, team readiness, and evidence completeness ahead of a scheduled inspection.
Cluster B: Supplier and commercial
Structured on-site or remote assessment of a supplier, CMO, or commercial partner against applicable GMP or GACP requirements.
Independent compliance evaluation on behalf of investors, acquirers, or commercial partners before committing to a relationship.
Cluster C: Regulatory pathway
Structured comparison of current state against applicable requirements. Produces a prioritised remediation roadmap before inspection date.
Verification audit to confirm that corrective actions from a previous finding have been implemented effectively.
Remote documentation assessment: SOPs, batch records, Site Master File, validation packages, quality agreements.
How we audit
Every engagement follows the same structured methodology regardless of audit type. Scope and deliverables are agreed before any site visit or document review begins.
Define the audit scope, applicable standards, site activities, objectives, and logistics. Agree on the deliverable format before starting.
Build a structured audit plan with criteria, scope, reference documents, agenda, and auditor allocation. Shared with the auditee before the engagement.
Confirm scope, method, timing, and contacts. Establish the working relationship and clarify any access requirements.
Systematic collection of evidence through document review, facility observation, interview, and process walkthrough. Documented at each step.
Present preliminary findings before leaving the site. Give the auditee the opportunity to clarify or provide additional evidence.
Deliver a written report with classified observations and recommended corrective actions. Follow-up structure defined for critical or major findings.
What you receive
Deliverables are scoped to the engagement type. The following list covers the full range across all audit formats.
Recognition
01
A regulatory inspection or certification audit is on the calendar with internal preparation still to begin.
02
The internal review shows no issues. An external audit before the inspection would confirm or challenge that assessment.
03
A supplier or CMO is critical to the supply chain but has never been audited by an independent third party.
04
Findings from a previous inspection or audit remain open or were closed without verified root cause analysis.
05
An investor, acquirer, or commercial partner is requesting independent compliance evidence before proceeding.
06
The quality team is too close to the system to see what an external auditor would find on day one.
Who requests an audit
You need periodic independent verification of systems you manage daily. Internal reviews have blind spots. An independent first-party audit provides the external perspective that satisfies your own QMS requirements.
Audit findings reached by your board, investor, or buyer carry more weight than internal reassurance. An independent audit report provides objective evidence that your operation meets the standards you claim.
Supplier qualification is a GMP requirement. Before onboarding a CMO, packaging supplier, or raw material source, a second-party audit verifies what the supplier data sheet alone leaves unanswered.
A competent authority inspection requires more than documentation. A mock inspection or pre-inspection gap analysis tests whether the site and the team can respond under the conditions that actually occur during an inspection day.
GMP compliance status determines market access, cost to remediate, and timeline to revenue. A due diligence audit provides an independent picture of gaps, risks, and what it takes to reach a certifiable state.
Consistency across sites requires periodic independent verification beyond shared SOPs. We support audit programme design, cross-site consistency assessment, and system-level review.
Describe the situation. We will identify the right audit type, scope, and format in a short call. There is no obligation to commit to an engagement before the scope is agreed.
Typical findings
These are real findings categories that appear repeatedly across first-party, second-party, and pre-inspection audits of cannabis and pharmaceutical operations.
FAQ
Scope is agreed before starting. Written report on completion. IRCA PR 325 certified lead auditor.